Page last updated: 2024-09-02

dynorphin (1-8) and levodopa

dynorphin (1-8) has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(dynorphin (1-8))
Trials
(dynorphin (1-8))
Recent Studies (post-2010)
(dynorphin (1-8))
Studies
(levodopa)
Trials
(levodopa)
Recent Studies (post-2010) (levodopa)
1730317,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomydynorphin (1-8) (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baronti, F; Berrettini, WH; Brughitta, G; Chase, TN; Conant, KE; Davis, TL; Giuffra, M; Iadarola, MJ; Mouradian, MM1

Other Studies

1 other study(ies) available for dynorphin (1-8) and levodopa

ArticleYear
Opioid peptides in Parkinson's disease: effects of dopamine repletion.
    Brain research, 1991, Sep-27, Volume: 560, Issue:1-2

    Topics: Adult; Aged; Aged, 80 and over; Dopamine; Dynorphins; Endorphins; Enkephalin, Methionine; Female; Homovanillic Acid; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Parkinson Disease; Peptide Fragments

1991